154 related articles for article (PubMed ID: 32759562)
1. [Treatment of iron overload in myelodysplastic syndromes and other bone marrow failure syndromes].
Kobune M
Rinsho Ketsueki; 2020; 61(7):753-763. PubMed ID: 32759562
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndromes and iron metabolism].
Kawabata H
Rinsho Ketsueki; 2018; 59(10):2042-2049. PubMed ID: 30305507
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes.
Cazzola M; Della Porta MG; Malcovati L
Hematology Am Soc Hematol Educ Program; 2008; ():166-75. PubMed ID: 19074076
[TBL] [Abstract][Full Text] [Related]
4. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in myelodysplastic syndromes (MDS).
Gattermann N
Int J Hematol; 2018 Jan; 107(1):55-63. PubMed ID: 29177643
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X
Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM
PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344
[TBL] [Abstract][Full Text] [Related]
8. Iron overload in myelodysplastic syndromes.
Mahesh S; Ginzburg Y; Verma A
Leuk Lymphoma; 2008 Mar; 49(3):427-38. PubMed ID: 18297518
[TBL] [Abstract][Full Text] [Related]
9. Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators.
Tsuge M; Kodera A; Sumitomo H; Araki T; Yoshida R; Yasui K; Sato H; Washio Y; Washio K; Shigehara K; Yashiro M; Yagi T; Tsukahara H
BMC Pediatr; 2022 Oct; 22(1):622. PubMed ID: 36309641
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and Anemia: A Tight Relationship.
Pagani A; Nai A; Silvestri L; Camaschella C
Front Physiol; 2019; 10():1294. PubMed ID: 31649559
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
Cuijpers ML; Raymakers RA; Mackenzie MA; de Witte TJ; Swinkels DW
Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561
[TBL] [Abstract][Full Text] [Related]
12. [The role of erythroferrone in iron metabolism: From experimental results to pathogenesis].
Vallet N;
Rev Med Interne; 2018 Mar; 39(3):178-184. PubMed ID: 28666715
[TBL] [Abstract][Full Text] [Related]
13. [Expression of iron-regulating erythroid factors in different types of erythropoiesis disorders].
Liu X; Hu J; Hu XR; Li XX; Guan DR; Liu JQ; Zhang YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):52-57. PubMed ID: 33677869
[No Abstract] [Full Text] [Related]
14. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
de Montalembert M; Ribeil JA; Brousse V; Guerci-Bresler A; Stamatoullas A; Vannier JP; Dumesnil C; Lahary A; Touati M; Bouabdallah K; Cavazzana M; Chauzit E; Baptiste A; Lefebvre T; Puy H; Elie C; Karim Z; Ernst O; Rose C
PLoS One; 2017; 12(3):e0172147. PubMed ID: 28257476
[TBL] [Abstract][Full Text] [Related]
15. Megaloblastic anemia-related iron overload and erythroid regulators: a case report.
Vallet N; Delaye JB; Ropert M; Foucault A; Ravalet N; Deriaz S; Chalopin T; Blasco H; Maillot F; Hérault O; Gyan E
J Med Case Rep; 2021 Sep; 15(1):463. PubMed ID: 34538261
[TBL] [Abstract][Full Text] [Related]
16. High erythroferrone expression in CD71
Riabov V; Mossner M; Stöhr A; Jann JC; Streuer A; Schmitt N; Knaflic A; Nowak V; Weimer N; Obländer J; Palme I; Schumann C; Baldus CD; Schulze TJ; Wuchter P; Röhl H; Jawhar A; Weiss C; Boch T; Metzgeroth G; Neumann M; Hofmann WK; Nolte F; Nowak D
Br J Haematol; 2021 Mar; 192(5):879-891. PubMed ID: 33486765
[TBL] [Abstract][Full Text] [Related]
17. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
[TBL] [Abstract][Full Text] [Related]
18. [Progress in iron metabolism research].
Kawabata H
Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietic regulators of iron metabolism.
Ganz T
Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
[TBL] [Abstract][Full Text] [Related]
20. New insights into iron regulation and erythropoiesis.
Kim A; Nemeth E
Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
